Evoq Remedies Ltd — Insider Trading, 30-03-2026: Insider Trading / SAST

Evoq Remedies has announced the closure of its trading window for Directors, Promoters, Designated Persons, and Insiders. This restriction on purchasing, selling, or dealing in the company's equity shares began on April 1st. The window will remain closed until 48 hours after the company declares and publishes its audited financial results for the half-year and full year ended March 31st. This measure ensures fair trading practices and prevents misuse of unpublished price-sensitive information by insiders ahead of the financial disclosure, which is important for all shareholders.